Tumor-derived Vascular Endothelial Growth Factor and Angiopoietin-2 in Non-small Cell Lung Cancer

Impact of vascular endothelial growth factor on prognosis of patients with hepatocellular carcinoma treated with angiotensin-converting-enzyme inhibitors

Prognostic Roles of Endostatin, Matrix Metalloproteinase-2 & 9 and Tissue Inhibitors of Metalloproteinase-1in Advanced Non-Small Cell Lung Cancer

ASSOCIATION OF SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL WITH ESTROGEN RECEPTORS STATUS IN BREAST CANCER PATIENTS.

ENDOSTATIN AND VEGF xxx b ARE POTENTIAL DIAGNOSTIC MARKERS FOR IDIOPATHIC PULMONARY FIBROSIS

Serum Vascular Endothelial Growth Factor Levels in Asthmatic Children

Diagnostic Role of Angiopoietin-2 and Vascular Endothelial Growth Factor in Malignant Pleural Effusion

Evaluating the Value of the Genetic Risk Variants of Haem-Oxygenase-1, Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 in Prediction of the Pr

Prognostic Factors of Non-Small Cell Lung Cancer and Their Relation to the Clinical Outcomes

Prognostic Factors for Platinum-Chemotherapy Response and Survival Outcomes in Patients with Advanced Stage Non-Small Cell Lung Cancer